UniProt ID | ING4_HUMAN | |
---|---|---|
UniProt AC | Q9UNL4 | |
Protein Name | Inhibitor of growth protein 4 | |
Gene Name | ING4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 249 | |
Subcellular Localization | Nucleus . | |
Protein Description | Component of the HBO1 complex which has a histone H4-specific acetyltransferase activity, a reduced activity toward histone H3 and is responsible for the bulk of histone H4 acetylation in vivo. Through chromatin acetylation it may function in DNA replication. May inhibit tumor progression by modulating the transcriptional output of signaling pathways which regulate cell proliferation. Can suppress brain tumor angiogenesis through transcriptional repression of RELA/NFKB3 target genes when complexed with RELA. May also specifically suppress loss of contact inhibition elicited by activated oncogenes such as MYC. Represses hypoxia inducible factor's (HIF) activity by interacting with HIF prolyl hydroxylase 2 (EGLN1). Can enhance apoptosis induced by serum starvation in mammary epithelial cell line HC11 (By similarity).. | |
Protein Sequence | MAAGMYLEHYLDSIENLPFELQRNFQLMRDLDQRTEDLKAEIDKLATEYMSSARSLSSEEKLALLKQIQEAYGKCKEFGDDKVQLAMQTYEMVDKHIRRLDTDLARFEADLKEKQIESSDYDSSSSKGKKKGRTQKEKKAARARSKGKNSDEEAPKTAQKKLKLVRTSPEYGMPSVTFGSVHPSDVLDMPVDPNEPTYCLCHQVSYGEMIGCDNPDCSIEWFHFACVGLTTKPRGKWFCPRCSQERKKK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
12 | Ubiquitination | MYLEHYLDSIENLPF HHHHHHHHHHHCCCH | 40.16 | 22817900 | |
17 | Ubiquitination | YLDSIENLPFELQRN HHHHHHCCCHHHHHH | 3.14 | 21890473 | |
34 | Ubiquitination | LMRDLDQRTEDLKAE HHHCHHHHHHHHHHH | 39.49 | 22817900 | |
37 | Ubiquitination | DLDQRTEDLKAEIDK CHHHHHHHHHHHHHH | 53.51 | 22817900 | |
39 | Ubiquitination | DQRTEDLKAEIDKLA HHHHHHHHHHHHHHH | 57.19 | 21890473 | |
42 | Ubiquitination | TEDLKAEIDKLATEY HHHHHHHHHHHHHHH | 7.27 | 21890473 | |
42 | Ubiquitination | TEDLKAEIDKLATEY HHHHHHHHHHHHHHH | 7.27 | 21890473 | |
44 | Ubiquitination | DLKAEIDKLATEYMS HHHHHHHHHHHHHHH | 45.76 | 29967540 | |
47 | Phosphorylation | AEIDKLATEYMSSAR HHHHHHHHHHHHHCC | 37.78 | - | |
49 | Phosphorylation | IDKLATEYMSSARSL HHHHHHHHHHHCCCC | 9.65 | - | |
50 | Ubiquitination | DKLATEYMSSARSLS HHHHHHHHHHCCCCC | 1.76 | 29967540 | |
51 | Phosphorylation | KLATEYMSSARSLSS HHHHHHHHHCCCCCH | 21.68 | 20068231 | |
52 | Phosphorylation | LATEYMSSARSLSSE HHHHHHHHCCCCCHH | 15.92 | 20068231 | |
61 | Ubiquitination | RSLSSEEKLALLKQI CCCCHHHHHHHHHHH | 34.70 | 22817900 | |
66 | Ubiquitination | EEKLALLKQIQEAYG HHHHHHHHHHHHHHH | 46.32 | 21890473 | |
66 | Ubiquitination | EEKLALLKQIQEAYG HHHHHHHHHHHHHHH | 46.32 | 22817900 | |
66 (in isoform 1) | Ubiquitination | - | 46.32 | 21890473 | |
66 (in isoform 2) | Ubiquitination | - | 46.32 | 21890473 | |
66 | Ubiquitination | EEKLALLKQIQEAYG HHHHHHHHHHHHHHH | 46.32 | 21890473 | |
66 | Ubiquitination | EEKLALLKQIQEAYG HHHHHHHHHHHHHHH | 46.32 | 21890473 | |
66 | Ubiquitination | EEKLALLKQIQEAYG HHHHHHHHHHHHHHH | 46.32 | 21890473 | |
74 | Ubiquitination | QIQEAYGKCKEFGDD HHHHHHHHHHHHCCH | 29.47 | 29967540 | |
88 | Acetylation | DKVQLAMQTYEMVDK HHHHHHHHHHHHHHH | 35.01 | 19608861 | |
95 | Ubiquitination | QTYEMVDKHIRRLDT HHHHHHHHHHHHHHH | 29.53 | - | |
112 | Ubiquitination | ARFEADLKEKQIESS HHHHHHHHHHHHHCC | 64.51 | - | |
112 | Acetylation | ARFEADLKEKQIESS HHHHHHHHHHHHHCC | 64.51 | 19608861 | |
114 | Acetylation | FEADLKEKQIESSDY HHHHHHHHHHHCCCC | 55.80 | 23749302 | |
114 (in isoform 4) | Acetylation | - | 55.80 | 19608861 | |
118 (in isoform 7) | Phosphorylation | - | 30.09 | 26270265 | |
118 | Phosphorylation | LKEKQIESSDYDSSS HHHHHHHCCCCCCCC | 30.09 | 23663014 | |
119 (in isoform 7) | Phosphorylation | - | 27.65 | 26270265 | |
119 | Phosphorylation | KEKQIESSDYDSSSS HHHHHHCCCCCCCCC | 27.65 | 23663014 | |
121 (in isoform 5) | Phosphorylation | - | 21.48 | - | |
121 (in isoform 7) | Phosphorylation | - | 21.48 | 26270265 | |
121 | Phosphorylation | KQIESSDYDSSSSKG HHHHCCCCCCCCCCC | 21.48 | 23663014 | |
122 | Acetylation | QIESSDYDSSSSKGK HHHCCCCCCCCCCCC | 47.21 | 19608861 | |
123 (in isoform 7) | Phosphorylation | - | 26.37 | 26270265 | |
123 (in isoform 5) | Phosphorylation | - | 26.37 | - | |
123 | Phosphorylation | IESSDYDSSSSKGKK HHCCCCCCCCCCCCC | 26.37 | 23663014 | |
124 (in isoform 7) | Phosphorylation | - | 35.42 | 26270265 | |
124 (in isoform 5) | Phosphorylation | - | 35.42 | - | |
124 | Phosphorylation | ESSDYDSSSSKGKKK HCCCCCCCCCCCCCC | 35.42 | 23663014 | |
124 | Acetylation | ESSDYDSSSSKGKKK HCCCCCCCCCCCCCC | 35.42 | 19608861 | |
125 | Phosphorylation | SSDYDSSSSKGKKKG CCCCCCCCCCCCCCC | 39.77 | 23663014 | |
125 (in isoform 7) | Phosphorylation | - | 39.77 | 26270265 | |
126 (in isoform 7) | Phosphorylation | - | 47.58 | 26270265 | |
126 | Phosphorylation | SDYDSSSSKGKKKGR CCCCCCCCCCCCCCC | 47.58 | 23663014 | |
127 | Acetylation | DYDSSSSKGKKKGRT CCCCCCCCCCCCCCC | 76.36 | 19608861 | |
127 (in isoform 4) | Acetylation | - | 76.36 | 19608861 | |
127 (in isoform 5) | Acetylation | - | 76.36 | - | |
129 | Acetylation | DSSSSKGKKKGRTQK CCCCCCCCCCCCCHH | 55.86 | 16916647 | |
130 | Acetylation | SSSSKGKKKGRTQKE CCCCCCCCCCCCHHH | 69.95 | 26051181 | |
130 (in isoform 4) | Phosphorylation | - | 69.95 | - | |
131 | Acetylation | SSSKGKKKGRTQKEK CCCCCCCCCCCHHHH | 58.05 | 69619 | |
132 | Acetylation | SSKGKKKGRTQKEKK CCCCCCCCCCHHHHH | 46.91 | 19608861 | |
133 | Citrullination | SKGKKKGRTQKEKKA CCCCCCCCCHHHHHH | 42.75 | 21454715 | |
133 | Citrullination | SKGKKKGRTQKEKKA CCCCCCCCCHHHHHH | 42.75 | - | |
136 | Acetylation | KKKGRTQKEKKAARA CCCCCCHHHHHHHHH | 71.53 | 7431291 | |
139 | Acetylation | GRTQKEKKAARARSK CCCHHHHHHHHHHHC | 48.66 | 19818205 | |
142 | Acetylation | QKEKKAARARSKGKN HHHHHHHHHHHCCCC | 35.08 | 19608861 | |
143 | Acetylation | KEKKAARARSKGKNS HHHHHHHHHHCCCCC | 18.51 | 19608861 | |
144 | Acetylation | EKKAARARSKGKNSD HHHHHHHHHCCCCCC | 33.09 | 19608861 | |
145 | Acetylation | KKAARARSKGKNSDE HHHHHHHHCCCCCCC | 44.79 | 19608861 | |
145 | Phosphorylation | KKAARARSKGKNSDE HHHHHHHHCCCCCCC | 44.79 | 28857561 | |
146 | Acetylation | KAARARSKGKNSDEE HHHHHHHCCCCCCCC | 69.24 | 19608861 | |
147 | Acetylation | AARARSKGKNSDEEA HHHHHHCCCCCCCCC | 35.31 | 19608861 | |
148 | Acetylation | ARARSKGKNSDEEAP HHHHHCCCCCCCCCC | 57.95 | 19608861 | |
150 | Phosphorylation | ARSKGKNSDEEAPKT HHHCCCCCCCCCCHH | 50.30 | 26055452 | |
152 | Acetylation | SKGKNSDEEAPKTAQ HCCCCCCCCCCHHHH | 56.74 | 19608861 | |
153 | Acetylation | KGKNSDEEAPKTAQK CCCCCCCCCCHHHHH | 75.22 | 19608861 | |
155 | Acetylation | KNSDEEAPKTAQKKL CCCCCCCCHHHHHHH | 37.50 | 19608861 | |
156 | Acetylation | NSDEEAPKTAQKKLK CCCCCCCHHHHHHHH | 64.64 | 19608861 | |
157 | Phosphorylation | SDEEAPKTAQKKLKL CCCCCCHHHHHHHHH | 33.01 | 26425664 | |
160 | Acetylation | EAPKTAQKKLKLVRT CCCHHHHHHHHHHHC | 58.57 | 26051181 | |
161 | Acetylation | APKTAQKKLKLVRTS CCHHHHHHHHHHHCC | 38.48 | 7668903 | |
166 | Citrullination | QKKLKLVRTSPEYGM HHHHHHHHCCCCCCC | 39.66 | - | |
166 | Citrullination | QKKLKLVRTSPEYGM HHHHHHHHCCCCCCC | 39.66 | 21454715 | |
167 (in isoform 8) | Phosphorylation | - | 40.95 | - | |
167 | Phosphorylation | KKLKLVRTSPEYGMP HHHHHHHCCCCCCCC | 40.95 | 26074081 | |
168 | Phosphorylation | KLKLVRTSPEYGMPS HHHHHHCCCCCCCCC | 12.74 | 26074081 | |
171 | Phosphorylation | LVRTSPEYGMPSVTF HHHCCCCCCCCCCEE | 23.31 | 26074081 | |
171 (in isoform 8) | Phosphorylation | - | 23.31 | - | |
212 | Acetylation | SYGEMIGCDNPDCSI CCCHHCCCCCCCCCE | 2.94 | 19608861 | |
232 | Acetylation | ACVGLTTKPRGKWFC EEECCCCCCCCCCCC | 27.73 | 19608861 | |
233 | Acetylation | CVGLTTKPRGKWFCP EECCCCCCCCCCCCC | 48.44 | 19608861 | |
235 | Acetylation | GLTTKPRGKWFCPRC CCCCCCCCCCCCCCC | 39.82 | 19608861 | |
236 | Acetylation | LTTKPRGKWFCPRCS CCCCCCCCCCCCCCC | 38.07 | 26051181 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ING4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ING4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ING4_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-112; LYS-127; LYS-146;LYS-148 AND LYS-156, AND MASS SPECTROMETRY. | |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-127; LYS-129; LYS-146 ANDLYS-148, AND MASS SPECTROMETRY. |